Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (2.174%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Net Asset Value - Ordinary Shares

14 Jul 2025 12:00

RNS Number : 8202Q
Marwyn Value Investors Limited
14 July 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

14 July 2025

 

Marwyn Value Investors Limited

Net Asset Value per Ordinary Share

 

The board of directors of Marwyn Value Investors Limited (the "Company") today announces that the estimated net asset value ("NAV") per ordinary share of the Company based on the estimated value of its interests in Marwyn Value Investors L.P. is £2.22239 as at 30 June 2025. As at 30 June 2025, there were 55,490,360 ordinary shares and 30,970,984 exchange shares in issue.

 

As at 30 June 2025 the closing mid share price of an ordinary share in the Company was £1.14500 and represented a discount of 48.48% to the NAV per ordinary share.

 

Historic NAV Performance

 

 

 

Estimated

NAV per share (£)

Movement over

Month (%)

Year to date

Movement (%)

Total Return Year to date (%)2

NAV Inception to date (%)1

Total Return Inception to date (%)2

2025:

 

June 30

2.22239

+2.2

+11.0

+13.4

+186.2

+302.6

May 31

2.17357

+2.0

+8.5

+10.9

+179.9

+293.7

April 30

2.12997

+1.8

+6.3

+7.5

+174.3

+281.8

March 31

2.09244

-0.8

+4.5

+5.6

+169.4

+275.0

February 28

2.10885

+4.9

+5.3

+6.5

+171.5

+278.0

January 31

2.01028

+0.4

+0.4

+0.4

+158.8

+256.4

2024:

 

December 31

2.00286

+5.3

+13.7

+19.4

+157.9

+255.0

November 30

1.90226

+0.5

+8.0

+13.4

+144.9

+237.2

October 31

1.89189

+0.9

+7.4

+11.4

+143.6

+231.4

September 30

1.87588

-0.7

+6.5

+10.5

+141.5

+228.6

August 31

1.88963

-1.8

+7.3

+11.3

+143.3

+231.0

July 31

1.92388

+3.0

+9.2

+12.0

+147.7

+233.0

June 30

1.86774

-1.0

+6.0

+8.7

+140.5

+223.2

May 31

1.88731

+2.1

+7.1

+9.8

+143.0

+226.6

April 30

1.84939

+0.5

+5.0

+6.3

+138.1

+216.2

March 31

1.83928

+1.9

+4.4

+5.7

+136.8

+214.5

February 29

1.80566

+1.4

+2.5

+3.8

+132.5

+208.7

January 31

1.78088

+1.1

+1.1

+1.1

+129.3

+200.6

 

 

 

NAV Allocation

 

Based upon the Company's indirect investments, the estimated allocation of the ordinary share NAV is:

 

 

Ordinary Shares

Total Value (£m)3

NAV/pence per Ordinary Share

% of NAV

Investment Portfolio

 

 

 

Quoted investments

AdvancedAdvT

26.7

48.2

21.7%

InvestAcc Group

36.5

65.8

29.6%

MAC Alpha

1.4

2.5

1.1%

Marwyn Acquisition Company III

5.9

10.6

4.8%

Zegona Communications

29.3

52.8

23.7%

450

3.8

6.9

3.1%

Unquoted investments

Le Chameau4

26.1

47.1

21.2%

Palmer

6.4

11.5

5.2%

Total Value

136.2

245.4

110.4%

Cash

2.8

5.1

2.3%

Other assets / liabilities

(15.7)

(28.3)

(12.7)%

Net Asset Value

123.3

222.2

100.0%

 

 

Notes

1The inception to date movement is based on the combined weighted average NAV of Marwyn Value Investors I, II and B shares prior to their amalgamation, using the conversion ratio published on 17 April 2008.

2The total return inception to date movement is based on the reinvestment of dividends paid to shareholders into the Company and is calculated on a cum-income basis.

3Portfolio investments are held at fair value in accordance with International Financial Reporting Standards ("IFRS"). Quoted investments with sufficient volume and frequency of trading to constitute an 'active market' under IFRS are held at their listed price on the valuation date. Unquoted investments, and quoted investments where there is no active market, are valued in accordance with International Private Equity and Venture Capital guidelines on a quarterly basis or whenever there is a material change in the investment which would indicate a significant change in valuation.

4The investment in Le Chameau is held through Silvercloud Holdings Limited ("Silvercloud"), with the value allocated to Le Chameau being the value attributable to each share class of Marwyn Value Investors L.P.'s holding in Silvercloud.

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

 

Enquiries to:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

 

Company secretary - Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

1 Grenville Street

St Helier

Jersey JE2 4UF

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVSFMFSLEISEDW
Date   Source Headline
3rd Jul 20204:03 pmRNSNet Asset Value
3rd Jul 20204:00 pmRNSNet Asset Value
26th Jun 20207:00 amRNSTransaction in Own Shares
25th Jun 20204:35 pmRNSNet Asset Value
25th Jun 20204:33 pmRNSNet Asset Value
22nd Jun 20207:00 amRNSTransaction in Own Shares
19th Jun 202010:55 amRNSNet Asset Value
19th Jun 202010:53 amRNSNet Asset Value
11th Jun 20205:48 pmRNSNet Asset Value
11th Jun 20205:46 pmRNSNet Asset Value
29th May 20208:00 amRNSDirector/PDMR Shareholding
28th May 20204:32 pmRNSNet Asset Value
28th May 20204:28 pmRNSNet Asset Value
28th May 20207:00 amRNSTransaction in Own Shares
27th May 202011:59 amRNSCompletion of Amended Accelerated Bookbuild
27th May 20207:00 amRNSAmended Accelerated Bookbuild
22nd May 20207:08 amRNSAccelerated Bookbuild
21st May 20205:27 pmRNSNet Asset Value
21st May 20205:25 pmRNSNet Asset Value
14th May 20206:03 pmRNSNet Asset Value
14th May 20205:59 pmRNSNet Asset Value
1st May 202011:51 amRNSNet Asset Value
1st May 202011:48 amRNSNet Asset Value
30th Apr 20204:48 pmRNSAudited Financial Statements December 2019
24th Apr 20208:59 amRNSNet Asset Value
24th Apr 20208:58 amRNSNet Asset Value
24th Apr 20207:00 amRNSTransaction in Own Shares
21st Apr 20207:00 amRNSTransaction in Own Shares
15th Apr 20205:42 pmRNSNet Asset Value
15th Apr 20205:41 pmRNSNet Asset Value
8th Apr 20207:00 amRNSTransaction in Own Shares
7th Apr 20207:00 amRNSTransaction in Own Shares
6th Apr 20207:00 amRNSTransaction in Own Shares
3rd Apr 202010:27 amRNSNet Asset Value
3rd Apr 202010:21 amRNSNet Asset Value
3rd Apr 20207:00 amRNSTransaction in Own Shares
26th Mar 20202:50 pmRNSNet Asset Value
26th Mar 20202:46 pmRNSNet Asset Value
24th Mar 20204:34 pmRNSExchange Procedure
20th Mar 20203:24 pmRNSNet Asset Value
20th Mar 20202:45 pmRNSNet Asset Value
13th Mar 202010:52 amRNSNet Asset Value
13th Mar 202010:48 amRNSNet Asset Value
9th Mar 20205:33 pmRNSNotification of major interests in shares
6th Mar 202012:40 pmRNSNet Asset Value
6th Mar 202012:37 pmRNSNet Asset Value
28th Feb 202010:47 amRNSNet Asset Value
28th Feb 202010:43 amRNSNet Asset Value
20th Feb 20204:33 pmRNSNet Asset Value
20th Feb 20204:32 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.